| Interprofessional spiritual care in oncology: a literature review CM Puchalski, A Sbrana, B Ferrell, N Jafari, S King, T Balboni, ... ESMO open 4 (1), e000465, 2019 | 146 | 2019 |
| Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) SE Rebuzzi, A Signori, GL Banna, M Maruzzo, U De Giorgi, P Pedrazzoli, ... Therapeutic advances in medical oncology 13, 17588359211019642, 2021 | 58 | 2021 |
| Use of procalcitonin in clinical oncology: a literature review A Sbrana, M Torchio, G Comolli, A Antonuzzo, M Danova New Microbiol 39 (3), 174-80, 2016 | 45 | 2016 |
| Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care A Antonuzzo, E Vasile, A Sbrana, M Lucchesi, L Galli, IM Brunetti, ... Supportive Care in Cancer 25, 209-212, 2017 | 34 | 2017 |
| AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer. M Del Re, S Crucitta, A Sbrana, E Rofi, F Paolieri, G Gianfilippo, L Galli, ... BJU International, 2019 | 26 | 2019 |
| Pancreatic resections for metastases: A twenty-year experience from a tertiary care center G Di Franco, D Gianardi, M Palmeri, N Furbetta, S Guadagni, M Bianchini, ... European Journal of Surgical Oncology 46 (5), 825-831, 2020 | 24 | 2020 |
| MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events J To, M Davis, A Sbrana, B Alderman, D Hui, S Mukhopadhyay, ... Supportive Care in Cancer 31 (4), 202, 2023 | 23 | 2023 |
| Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer B Alderman, D Hui, S Mukhopadhyay, C Bouleuc, AA Case, K Amano, ... Supportive Care in Cancer 31 (1), 39, 2023 | 20 | 2023 |
| Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology: a real-world study on behalf of Meet-URO Group (MeetUro-7b) M Stellato, D Santini, E Verzoni, U De Giorgi, F Pantano, C Casadei, ... Frontiers in oncology 11, 682449, 2021 | 20 | 2021 |
| Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists M Ottaviano, M Curvietto, P Rescigno, M Tortora, G Palmieri, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 20 | 2020 |
| The role of automated cytometry in the new era of cancer immunotherapy M Danova, M Torchio, G Comolli, A Sbrana, A Antonuzzo, G Mazzini Molecular and clinical oncology 9 (4), 355-361, 2018 | 19 | 2018 |
| [18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer F Pasqualetti, M Panichi, M Sollini, A Sainato, L Galli, R Morganti, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 185-191, 2020 | 18 | 2020 |
| Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM) AC Tralongo, A Antonuzzo, P Pronzato, A Sbrana, M Turrini, F Zoratto, ... Tumori Journal 106 (4), 273-280, 2020 | 16 | 2020 |
| Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression G De Feo, AA Case, GB Crawford, D Hui, J To, A Sbrana, B Alderman, ... Supportive Care in Cancer 31 (3), 176, 2023 | 15 | 2023 |
| Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer M Del Re, S Crucitta, A Sbrana, E Rofi, F Paolieri, G Gianfilippo, L Galli, ... BJU international 124 (4), 693-700, 2019 | 15 | 2019 |
| Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (IO): a meet-URO group real world study (Meet-Uro 7) D Santini, M Stellato, U De Giorgi, F Pantano, D De Lisi, C Casadei, ... American Journal of Clinical Oncology 44 (3), 121-125, 2021 | 14 | 2021 |
| Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase … R Caputo, ME Cazzaniga, A Sbrana, R Torrisi, I Paris, M Giordano, ... BMC cancer 20, 1-9, 2020 | 14 | 2020 |
| CYP17A1 polymorphism c.-362T> C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone S Crucitta, M Del Re, F Paolieri, F Bloise, A Sbrana, E Sammarco, ... Cancer Chemotherapy and Pharmacology 86, 527-533, 2020 | 14 | 2020 |
| Muscle function impairment in cancer patients in pre-cachexia stage S Dalise, P Tropea, L Galli, A Sbrana, C Chisari European journal of translational myology 30 (2), 2020 | 14 | 2020 |
| Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy P Bossi, L Botta, P Bironzo, C Sonetto, G Musettini, A Sbrana, ... Future Oncology 15 (21), 2543-2553, 2019 | 14 | 2019 |
